Allicin ameliorates doxorubicin-induced cardiotoxicity in rats via suppression of oxidative stress, inflammation and apoptosis

Purpose Doxorubicin (DOX) is a highly active antineoplastic agent; however, its clinical use is limited due to associated cardiotoxicity. This study was performed to evaluate the beneficial effects of allicin, a dietary garlic active constituent against DOX-induced cardiotoxicity. Methods Forty male...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer chemotherapy and pharmacology Jg. 80; H. 4; S. 745 - 753
Hauptverfasser:	Abdel-Daim, Mohamed M., kilany, Omnia E., Khalifa, Hesham A., Ahmed, Amal A. M.
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Berlin/Heidelberg Springer Berlin Heidelberg 01.10.2017 Springer Nature B.V
Schlagworte:	Animals Antibiotics, Antineoplastic - toxicity Antioxidants Antioxidants - administration & dosage Antioxidants - pharmacology Apoptosis Apoptosis - drug effects Biomarkers - blood Cancer Research Cardiotoxicity Cardiotoxicity - etiology Cardiotoxicity - prevention & control Caspase Caspase-3 Catalase Creatine Creatine kinase Cyclooxygenase-2 Cytokines Cytokines - metabolism Dose-Response Relationship, Drug Doxorubicin Doxorubicin - toxicity Glutathione peroxidase Heart Heart diseases Inflammation Inflammation - chemically induced Inflammation - prevention & control Intoxication L-Lactate dehydrogenase Lactic acid Male Malondialdehyde Malondialdehyde - metabolism Medicine Medicine & Public Health Mice Nitric oxide Nitric Oxide - metabolism Oncology Original Article Oxidative stress Oxidative Stress - drug effects Pharmacology/Toxicology Rodents Serum levels Sulfinic Acids - administration & dosage Sulfinic Acids - pharmacology Superoxide dismutase Heart Oxidative damage Adriamycin Inflammation Garlic Cardiotoxicity Antioxidant Anti-inflammatory Apoptosis
ISSN:	0344-5704, 1432-0843, 1432-0843
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!